MYASTHENIA GRAVIS, OCULAR

Clinical trials for MYASTHENIA GRAVIS, OCULAR explained in plain language.

Never miss a new study

Get alerted when new MYASTHENIA GRAVIS, OCULAR trials appear

Sign up with your email to follow new studies for MYASTHENIA GRAVIS, OCULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Weekly shot tested to fight debilitating eye weakness

Disease control Recruiting now

This study is testing if a weekly injection called telitacicept can better control the symptoms of ocular myasthenia gravis, a condition that causes muscle weakness around the eyes. About 120 participants, aged 12 to 80, will receive either the drug or a placebo for 24 weeks whil…

Matched conditions: MYASTHENIA GRAVIS, OCULAR

Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

MYASTHENIA GRAVIS, OCULAR

Get alerted when new MYASTHENIA GRAVIS, OCULAR trials appear

Weekly shot tested to fight debilitating eye weakness